Monthly continuous erythropoietin receptor activator treatment maintains stable hemoglobin levels in routine clinical management of hemodialysis patients
- 作者Thomas Weinreich; Frank Leistikow; Hagen-Georg Hartmann; Günter Vollgraf; Frank Dellanna; the SESAM Study Group
- 卷第16卷
- 期第1期
- 印刷ISSN1492-7535
- 电子ISSN1542-4758
- 文件大小210.50KB
- 发表时间2012
- DOI10.1111/j.1542-4758.2011.00608.x
同作者推荐
Management of hypertension and dyslipidemiaKeith C. Ferdinand; Myra A. Kleinpeter · 2006
Early Detection of Renal Disease/Microalbuminuria in Patients With the Cardiometabolic SyndromeMyra A. Kleinpeter · 2007
Circulating Adipocytokines and Chronic Kidney DiseaseMills, Katherine T.; Hamm, L. Lee; Alper, A. Brent; Miller, Chad; Hudaihed, Alhakam; Balamuthusamy, Saravanan; Chen, Chung-Shiuan; Liu, Yanxi; Tarsia, Joseph; Rifai, Nader; Kleinpeter, Myra; He, Jiang; Chen, Jing; Stover, Cordula M. · PLoS ONE · 2013
End-Stage Renal Disease Use in Hurricane-Prone Areas: Should Nephrologists Increase the Utilization of Peritoneal Dialysis?Kleinpeter, Myra A. · 2007